From formulation development through global clinical trials to final approval, Symbio provides specialized experience and expertise in clinical research. Our global studies have helped pave the way to advancements in dermatology, ophthalmology, women’s health and internal medicine since 2002.
SPECIALISTS IN DERMATOLOGY CLINICAL TRIALS
From North America to Europe to Latin America, our global Clinical Research Organization (CRO) team has managed more than 150 dermatology clinical trials, resulting in over 50 FDA approvals. As leading experts in dermatology research, Symbio specializes in many areas of dermatology trials including, but not limited to Acne, Psoriasis, Atopic Dermatitis, Rosacea, Actinic Keratosis, Tinea Pedis, Onychomycosis and more.
200
Phase 1-4 Clinical Trials
65000
Subjects
1200
Investigators and Clinical Sites
51
FDA Approvals
Home
A Clinical Research Organization that Exceeds All Expectations
Symbio, LLC is a client-focused, global Clinical Research Organization (CRO) with world-class qualifications in the development of therapeutic drugs. We provide a full suite of industry-leading services to sponsors, including:
Project Management – experienced project management team that best suits your needs
Data Management – in-house database design and user-friendly electronic data capture
Medical Monitoring Services – in-house Medical Monitor offering over 30 years of experience
BioStatistics – experienced statisticians with extensive knowledge in clinical programs translating clinical thought into statistical data analysis
Site Selection – extensive investigator database
Monitoring – in-house monitors with extensive experience
Medical Writing – fast turnaround times for protocol development and clinical study reports
Subject Recruitment – proactive services to shorten enrollment timelines, track and monitor enrollment
We operate all of the core services of our Clinical Research Organization in-house at offices in both the United States and Europe.
Extensive Experience in Clinical Research
Symbio’s executive leadership team has decades of experience in the clinical development of therapeutic medications. Our experienced personnel strategically manage every aspect of clinical trials. We pride ourselves on providing outstanding service every step of the way, from formulation through to final approval.
In conjunction with our subsidiary, Dow Development Laboratories, LLC, Symbio provides a turnkey CRO solution, which includes the design, development and topical formulation of drug products.
Symbio is firmly committed to delivering outstanding service and quality to our sponsors and investigators. Our full-service, global Clinical Research Organization strives to bring every clinical study to a successful conclusion, on time and on budget.
“The reward for providing great work is being awarded with additional studies and projects. Symbio is here to help Sponsors get studies done – whatever it takes.”
RICHARD PANICO, MBA
President, Symbio, LLC and CEO, Symbio in Europe: SRE GmbH
Symbio Research
2019-02-03T19:11:06+00:00
“The reward for providing great work is being awarded with additional studies and projects. Symbio is here to help Sponsors get studies done – whatever it takes.” RICHARD PANICO, MBA President, Symbio, LLC and CEO, Symbio in Europe: SRE GmbH
“Clinical research is a huge group effort. Our Symbio staff understands that we are all in this together, we all want to be part of something successful and work hard to make that happen.”
DEBRA DOW, PharmD, MBA
Vice President, Scientific Affairs, Symbio, LLC
Symbio Research
2019-02-03T19:11:54+00:00
“Clinical research is a huge group effort. Our Symbio staff understands that we are all in this together, we all want to be part of something successful and work hard to make that happen.” DEBRA DOW, PharmD, MBA Vice President, Scientific Affairs, Symbio, LLC
“Clinical Research is a complex undertaking. I believe that clarity is one of the most important drivers for success in clinical research, and I am happy to add clarity for successfully navigating through the EU clinical trial landscape.”
VERONIKA KUNERT, BSc
COO, Symbio in Europe: SRE GmbH
Symbio Research
2019-02-03T19:12:31+00:00
“Clinical Research is a complex undertaking. I believe that clarity is one of the most important drivers for success in clinical research, and I am happy to add clarity for successfully navigating through the EU clinical trial landscape.” VERONIKA KUNERT, BSc COO, Symbio in Europe: SRE GmbH
Symbio and Dow Development Laboratories will be at AAD 2020 in Booth #1347 and #1348. We will keep you updated with news and information as the date gets closer.
more
Symbio and Dow Development Laboratories exhibited at the 28th EADV Congress, “The Modern Face of Dermatology” from October 9 to October 13, 2019 at IFEMA Congress Centre in Madrid, Spain. The...
more
Symbio and Dow Development Laboratories were glad to exhibit at the 2019 AAD Annual Meeting from March 1 to March 5, 2019 at the Walter E. Washington Convention Center in...
more
Symbio and Dow Development Laboratories were at the 5th Annual Dermatology Innovation Forum on February 28, 2019 from 8am to 5pm at the Washington Hilton in Washington, DC. As a...
more
Europe may seem small considering only about 10% of the world’s population lives there, but it’s the second largest region by the number of studies conducted according to clinicaltrials.gov. The...
more
Symbio exhibited at the 24th World Congress of Dermatology from June 10 to June 15, 2019 at MiCo – Milano Congressi in Milan, Italy.
more
COVID-19 - Symbio continues to successfully manage clinical trials through the technology we've utilized for years and quickly implemented a company-wide COVID Plan, carefully considered Monitoring Plans, and detailed study-specific COVID-19 plans following FDA and other guidelines.
Ask Symbio about how we can conduct your trial during this time.
Symbio uses cookies to enhance your experience, to display customized content in accordance with your browser settings, and to help us better understand how you use our website. By continuing to browse or closing this banner, you indicate your agreement.OkPrivacy policy
